Literature DB >> 19540918

Vascular deposition of complement C4d is increased in liver allografts with chronic rejection.

Timi Martelius1, Leena Halme, Johanna Arola, Krister Höckerstedt, Irmeli Lautenschlager.   

Abstract

BACKGROUND: Complement protein C4d has been used as a marker of antibody mediated rejection in kidney allografts. C4d has been shown to be deposited also in chronic kidney allograft rejection, and frequently in acute liver allograft rejection. In chronic liver allograft rejection there is limited data of C4d positivity.
METHODS: 7 liver allografts explanted at retransplantation due to chronic rejection were examined for expression of C4d. Immunoperoxidase technique on frozen sections was used. The "zero" biopsies of the same livers at the first transplantation served as controls.
RESULTS: Expression of C4d was significantly increased in portal and central veins as well as in the portal stroma of the grafts with chronic rejection when compared to the expression at implantation of the graft.
CONCLUSION: The complement system and anti-donor antibodies may contribute to the process of chronic allograft rejection in the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540918     DOI: 10.1016/j.trim.2009.06.004

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  6 in total

1.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

Review 2.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

Review 3.  The role of B cells in solid organ transplantation.

Authors:  Jean Kwun; Pinar Bulut; Eugenia Kim; Wasim Dar; Byoungchol Oh; Ravi Ruhil; Neal Iwakoshi; Stuart J Knechtle
Journal:  Semin Immunol       Date:  2011-12-01       Impact factor: 11.130

4.  Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution.

Authors:  Mohannad Dugum; Medhat Askar; Rish K Pai; Lisa Yerian; Ana Bennett; James McMahon; Hao Xie; Bijan Eghtesad; Ibrahim Hanouneh; Xiuli Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 5.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

6.  Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.

Authors:  Yoshihiro Hirata; Atsushi Yoshizawa; Hiroto Egawa; Daisuke Ueda; Shinya Okamoto; Hideaki Okajima; Kimiko Yurugi; Rie Hishida; Hideyo Hirai; Aya Miyagawa-Hayashino; Taira Maekawa; Hironori Haga; Sinji Uemoto
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.